Literature DB >> 2979003

A pharmacologic study of the sympathetic eyelid tarsal muscles.

D P Felt1, B R Frueh.   

Abstract

The contractile state of the sympathetically innervated superior and inferior tarsal muscles, also known as Mueller's muscles, was defined in 10 young adults by stimulating and then paralyzing these muscles pharmacologically in a randomized, double-masked study, using one eye for drug and the other for control. The drugs used topically were phenylephrine hydrochloride 2.5 and 10% for muscle stimulation, and guanethidine 5% and thymoxamine hydrochloride 0.5% for muscle inhibition. A model is described for accurately examining and recording changes in the vertical palpebral fissure simultaneously bilaterally using magnified images from two high-resolution, high-sensitivity video cameras. The superior tarsal muscle averaged 50% of its total possible contraction when it was in its tonic state, and the inferior tarsal muscle averaged 67%. The drug instillations defined the mean maximum total excursion of the superior tarsal muscle as 3.0 mm, with 1.5 mm of upward displacement and 1.5 mm of downward displacement from its tonic position. The inferior tarsal muscle had a mean maximum total excursion of 0.3 mm, with 0.1 mm downward displacement and 0.2 mm upward displacement from its tonic position.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2979003     DOI: 10.1097/00002341-198801130-00003

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  2 in total

1.  A Contractile Network of Interstitial Cells of Cajal in the Supratarsal Mueller's Smooth Muscle Fibers With Sparse Sympathetic Innervation.

Authors:  Shunsuke Yuzuriha; Kiyoshi Matsuo; Ryokuya Ban; Shiharu Yano; Tetsuji Moriizumi
Journal:  Eplasty       Date:  2012-02-15

2.  Palpebral Fissure Response to Phenylephrine Indicates Autonomic Dysfunction in Patients With Type 1 Diabetes and Polyneuropathy.

Authors:  Thomas Arendt Nielsen; Carl Uggerhøj Andersen; Henrik Vorum; Sam Riahi; Rok Sega; Asbjørn Mohr Drewes; Jesper Karmisholt; Poul Erik Jakobsen; Birgitte Brock; Christina Brock
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-08-02       Impact factor: 4.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.